Corporate News     04-Jun-24
Shilpa Biologicals files first Drug Master File of recombinant Human Albumin 20% with USFDA
Shilpa Biologicals, a wholly owned subsidiary of Shilpa Medicare has filed its first Drug Master File of recombinant Human Albumin 20% with USFDA.

This novel recombinant has been developed and is a patented novel recombinant Human Albumin 20% process which is completely-Environment friendly, Consistent High-Quality product, Scalable to massive scales and is cost competitive.

Recombinant Human Albumin 20% targets to fulfil growing demand of human serum albumin to deliver current and growing market demand.

Previous News
  Shilpa Medicare standalone net profit declines 54.08% in the March 2021 quarter
 ( Results - Announcements 31-May-21   16:04 )
  Shilpa Medicare board OKs rights issue upto Rs 325 cr
 ( Hot Pursuit - 23-Jun-23   15:33 )
  Shilpa Medicare spurts after Bengaluru facility gets GMP certificate
 ( Hot Pursuit - 13-Jul-22   10:20 )
  Board of Shilpa Medicare approves rights issue of Rs 325 cr
 ( Corporate News - 23-Jun-23   14:41 )
  Shilpa Medicare launches India's First Women intimate cleansing spray - SwatchShil
 ( Corporate News - 04-Mar-21   11:46 )
  Shilpa Medicare to conduct EGM
 ( Corporate News - 27-Apr-22   11:52 )
  Shilpa Medicare launches anti-cancer drug - IBRUSHIL
 ( Corporate News - 28-May-20   11:27 )
  Volumes soar at Havells India Ltd counter
 ( Hot Pursuit - 05-Feb-20   11:00 )
  Shilpa Medicare advances after securing USFDA approval
 ( Hot Pursuit - 16-Nov-18   12:21 )
  Shilpa Medicare consolidated net profit declines 77.35% in the March 2021 quarter
 ( Results - Announcements 31-May-21   16:08 )
  Shilpa Medicare fixes record date for interim dividend
 ( Market Beat - Reports 20-Feb-18   09:29 )
Other Stories
  GRP schedules AGM
  01-Jul-24   20:01
  Mahindra & Mahindra domestic PV sales jump 23% in June
  01-Jul-24   20:01
  Vipul Organics constructs new factory in Ambernath, Maharashtra
  01-Jul-24   20:00
  Greaves Engineering launches range of new CPCB IV+ Compliant Gensets
  01-Jul-24   19:41
  Godrej Properties to develop 7-acre land in Thanisandra, North Bengaluru
  01-Jul-24   19:39
  Rama Phosphates AGM scheduled
  01-Jul-24   19:34
  Take Solutions to convene AGM
  01-Jul-24   19:34
  Fischer Medical Ventures partners with Singapore-based Nervotec
  01-Jul-24   19:29
  NIIT appoints Pankaj Jathar as Chief Executive Officer
  01-Jul-24   19:27
  Dynacons Systems recognized as India's Leading Listed ESG Entities 2024
  01-Jul-24   19:26
Back Top